Tailoring Antiplatelet Adherence
Authors:
- Rudra Pratap SinghRSRudra Pratap Singh
- Breandan KellyBKBreandan Kelly
- Seerat SachdevaSSSeerat Sachdeva
- Stephanie RosenbergSRStephanie Rosenberg
- Harmon R. CannonHCHarmon R. Cannon
- Linda MacdonaldLMLinda Macdonald
Open Access
- 16 September 2026
- journal article
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (37)
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary SyndromesJACC, 2025
- CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart AssociationCirculation, 2024
- Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCIJACC: Cardiovascular Interventions, 2023
- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke AssociationStroke, 2021
- Oral Antiplatelet Therapy After Acute Coronary SyndromeJAMA, 2021
- Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet TherapyJACC: Cardiovascular Interventions, 2017